CCB-003

N/A

Report date: 2023/02/19 23:42:26

Base Information

Drug NameCCB-003
Drug Alias NameCCB003
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsEhlers-Danlos Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesCastle Creek Biosciences LLC
Inactive CompaniesN/A
Active IndicationsEhlers-Danlos Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A